Women with high-risk HER2-negative breast cancer when treated with immunotherapy before surgery and a PARP inhibitor with chemotherapy, have a higher chance of complete eradication of cancer from the breast and lymph nodes compared to chemotherapy alone.
from Medindia Health News https://ift.tt/2Wc48Ab
No comments:
Post a Comment